0001127602-23-022117.txt : 20230807 0001127602-23-022117.hdr.sgml : 20230807 20230807160517 ACCESSION NUMBER: 0001127602-23-022117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230803 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASPER MARC N CENTRAL INDEX KEY: 0001216055 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08002 FILM NUMBER: 231147559 MAIL ADDRESS: STREET 1: C/O THERMO FISHER SCIENTIFIC STREET 2: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERMO FISHER SCIENTIFIC INC. CENTRAL INDEX KEY: 0000097745 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 042209186 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7816221000 MAIL ADDRESS: STREET 1: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: THERMO ELECTRON CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-08-03 0000097745 THERMO FISHER SCIENTIFIC INC. TMO 0001216055 CASPER MARC N 168 THIRD AVENUE WALTHAM MA 02451 1 1 Chairman & CEO 1 Common Stock 2023-08-03 4 M 0 10000 157.68 A 151329.53 D Common Stock 2023-08-03 4 S 0 300 545.66 D 151029.53 D Common Stock 2023-08-03 4 S 0 1600 547.43 D 149429.53 D Common Stock 2023-08-03 4 S 0 3000 548.25 D 146429.53 D Common Stock 2023-08-03 4 S 0 1900 549.38 D 144529.53 D Common Stock 2023-08-03 4 S 0 2100 550.33 D 142429.53 D Common Stock 2023-08-03 4 S 0 1100 551.09 D 141329.53 D Common Stock 2023-08-03 5 G 0 E 3300 0 D 0 I By Spouse Common Stock 2023-08-03 5 G 0 E 3300 0 A 5300 I By Alison Casper 2020 Irrevocable Trust Common Stock 2023-08-03 5 G 0 E 6000 0 D 135329.53 D Common Stock 2023-08-03 5 G 0 E 6000 0 A 6000 I By Spouse Common Stock 2023-08-04 4 M 0 10000 157.68 A 145329.53 D Common Stock 2023-08-04 4 S 0 1200 547.55 D 144129.53 D Common Stock 2023-08-04 4 S 0 1627 548.61 D 142502.53 D Common Stock 2023-08-04 4 S 0 2400 549.57 D 140102.53 D Common Stock 2023-08-04 4 S 0 1441 550.40 D 138661.53 D Common Stock 2023-08-04 4 S 0 1432 551.49 D 137229.53 D Common Stock 2023-08-04 4 S 0 600 552.72 D 136629.53 D Common Stock 2023-08-04 4 S 0 900 553.76 D 135729.53 D Common Stock 2023-08-04 4 S 0 400 554.56 D 135329.53 D Common Stock 59155 I By Floral Park Associates, Inc. Common Stock 5000 I By MNC 2020 Irrevocable Trust Stock Option (Right to Buy) 157.68 2023-08-03 4 M 0 10000 0 D 2024-02-28 Common Stock 10000 53200 D Stock Option (Right to Buy) 157.68 2023-08-04 4 M 0 10000 0 D 2024-02-28 Common Stock 10000 43200 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.835 to $547.83, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (9), (10), (11), (12), (13), (14), (15) and (16) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.84 to $548.83, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.84 to $549.835, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.84 to $550.815, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.845 to $551.41, inclusive. Effective February 27, 2023, donations of equity securities are to be reported on a Form 4 within two business days rather than on Form 5 within 45 days after the end of the fiscal year. Although the identifying "V" for donations made before February 27 and reported early on Form 4, the "V' is not appropriate for the donation reported on this Form 4. The "V" is included here due solely to a limitation in the issuer's filing software which is currently being reprogrammed. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.99 to $547.97, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.03 to $549.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.04 to $550.01, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.06 to $550.95, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.12 to $551.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.18 to $553.06, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.19 to $554.155, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.31 to $554.83, inclusive. The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021. /s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper 2023-08-07